Drew is a problem solver with twenty years of regulatory, compliance, and quality management experience including substantial time with the US Food and Drug Administration. He maintains knowledge of global pharmaceutical CMC regulations and guidance documents pertaining to products in clinical development through post marketing applications, and is a champion of phase-appropriate and risk-based approaches for each phase of pharmaceutical development. Prior to joining Syner-G, Drew worked in Regulatory Affairs leadership roles at Alkermes and Vertex.